Asia-Pacific
A fresh wave of deals highlights why investors favour IP firms and why independent outfits may soon have to rethink their strategy
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Ranjna Mehta-Dutt, who moved to Chadha & Chadha after 25 years at Remfry & Sagar, says the firm plans to expand its life sciences practice through targeted recruitment and dedicated teams for bigger clients
Law firms across the world are seemingly united in their reluctance to give juniors a chance, which shouldn’t be the case
Sponsored
Sponsored
-
Sponsored by Lifang & PartnersYan Zhang and Lin Mu of Lifang & Partners explain how a recent case involving the VANS trademark shows how punitive damages are applied in China -
Sponsored by AJ ParkKate Giddens, senior associate at AJ Park and member of the IPONZ Trade mark Technical Focus Group, summarises the key trademark trends seen in New Zealand in 2021, shaping the landscape for what 2022 might bring
-
Sponsored by Wanhuida Intellectual PropertyXiaohui Wu, Yuming Wang and Jianhui Li of Wanhuida Intellectual Property discuss the Supreme People’s Court’s first decision in parallel civil and administrative proceedings involving a chiral drug patent
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law looks at the safeguards available as the separated application comes into effect in South Korea during April 2022
-
Sponsored by FB RiceSarah Dixon of FB Rice asks what the emergence of the metaverse and the increase in virtual reality platforms mean for trademark owners in Australia
-
Sponsored by Saint Island International Patent & Law OfficesTony TY Chang of Saint Island International Patent & Law Offices reviews the recent decision of the IPC Court concerning the DABUS patent application
